ES8102120A1 - Procedimiento para la obtencion de derivados de pirazol - Google Patents

Procedimiento para la obtencion de derivados de pirazol

Info

Publication number
ES8102120A1
ES8102120A1 ES488717A ES488717A ES8102120A1 ES 8102120 A1 ES8102120 A1 ES 8102120A1 ES 488717 A ES488717 A ES 488717A ES 488717 A ES488717 A ES 488717A ES 8102120 A1 ES8102120 A1 ES 8102120A1
Authority
ES
Spain
Prior art keywords
pyrazole derivatives
production
pharmaceutical preparations
preparations containing
phenylpiperazino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES488717A
Other languages
English (en)
Other versions
ES488717A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of ES488717A0 publication Critical patent/ES488717A0/es
Publication of ES8102120A1 publication Critical patent/ES8102120A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE PIRAZOL, DE FORMULA (I): EN LA QUE R ELEVADO A 1 SIGNIFICA H O C1; R ELEVADO A 2 SIGNIFICA 1-METIL-4-PIPERIDILOXICARBONILO, 2-(4-FENILPIPERAZINO). CARACTERIZADO PORQUE SE HACE REACCIONAR UN COMPUESTO DE FORMULA GENERAL (II): *FORMULA* O UNO DE SUS DERIVADOS REACTIVOS, CON FENILHIDRAZINA O UNA DE SUS SALES; TAMBIEN SE REVINDICAN OTROS PROCEDIMIENTOS DE OBTENCION. ESTOS DERIVADOS SE EMPLEAN EN LA MEDICINA HUMANA O ANIMAL.
ES488717A 1979-02-19 1980-02-18 Procedimiento para la obtencion de derivados de pirazol Expired ES8102120A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792906252 DE2906252A1 (de) 1979-02-19 1979-02-19 Pyrazolderivate, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
ES488717A0 ES488717A0 (es) 1980-12-16
ES8102120A1 true ES8102120A1 (es) 1980-12-16

Family

ID=6063264

Family Applications (1)

Application Number Title Priority Date Filing Date
ES488717A Expired ES8102120A1 (es) 1979-02-19 1980-02-18 Procedimiento para la obtencion de derivados de pirazol

Country Status (8)

Country Link
US (1) US4258047A (es)
EP (1) EP0014847A1 (es)
JP (1) JPS55120583A (es)
AU (1) AU5556280A (es)
DE (1) DE2906252A1 (es)
ES (1) ES8102120A1 (es)
IL (1) IL59410A0 (es)
ZA (1) ZA80922B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826868A (en) * 1986-05-29 1989-05-02 Ortho Pharmaceutical Corporation 1,5-Diaryl-3-substituted pyrazoles pharmaceutical compositions and use
AU611437B2 (en) * 1987-05-29 1991-06-13 Ortho Pharmaceutical Corporation Pharmacologically active 2- and 3-substituted (1',5'-diaryl-3-pyrazolyl)-n-hydroxypropanamides and method for synthesizing the same
PH27357A (en) * 1989-09-22 1993-06-21 Fujisawa Pharmaceutical Co Pyrazole derivatives and pharmaceutical compositions comprising the same
GB9714303D0 (en) * 1997-07-07 1997-09-10 Pharmacia & Upjohn Spa 5-(3-phenyl-3-oxo-propyl)-1H-tetrazole derivatives
DE10149370A1 (de) * 2001-10-06 2003-04-10 Merck Patent Gmbh Pyrazolderivate
AU2003275637A1 (en) * 2002-10-24 2004-05-13 Wakamoto Pharmaceutical Co., Ltd. Pyrazole-4-alkanoate derivatives inhibiting cyclooxygenase and 5-lipoxygenase
DE10315572A1 (de) * 2003-04-05 2004-10-14 Merck Patent Gmbh Substituierte Pyrazole
DE10315571A1 (de) 2003-04-05 2004-10-14 Merck Patent Gmbh Pyrazolverbindungen
DE10315569A1 (de) 2003-04-05 2004-10-14 Merck Patent Gmbh Substituierte Pyrazolverbindungen
DE10315573A1 (de) 2003-04-05 2004-10-14 Merck Patent Gmbh Substituierte Pyrazole
CN101528740B (zh) * 2006-09-29 2012-09-19 株式会社绿十字 作为大麻素cb1受体拮抗剂的杂芳基-吡唑衍生物
WO2009078498A1 (en) * 2007-12-17 2009-06-25 Green Cross Corporation Biarylpyrazole 4-carboxamides as cannabinoid cb1 receptor ligands

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE663344A (es) * 1964-05-04
DE1595920B2 (de) * 1964-11-04 1978-08-10 Merck Patent Gmbh, 6100 Darmstadt 4-(co-Piperazinoalkyl)-pyrazole, ihre Salze und Verfahren zu ihrer Herstellung
CH535777A (de) * 1967-03-01 1973-04-15 Ciba Geigy Ag Verfahren zur Herstellung neuer azacycloaliphatischer Verbindungen
BE755924A (fr) * 1969-09-12 1971-02-15 Byk Gulden Lomberg Chem Fab Derives d'acide pyrazole-4-acetique, leur procede de preparation et medicaments en contenant
DE2526469A1 (de) * 1975-06-13 1976-12-30 Bayer Ag 1-substituierte pyrazolderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
EP0014847A1 (de) 1980-09-03
IL59410A0 (en) 1980-05-30
ES488717A0 (es) 1980-12-16
JPS55120583A (en) 1980-09-17
ZA80922B (en) 1981-02-25
US4258047A (en) 1981-03-24
AU5556280A (en) 1980-08-28
DE2906252A1 (de) 1980-08-28

Similar Documents

Publication Publication Date Title
ES8304143A1 (es) "procedimiento para la preparacion de derivados de cefem".
ES8802220A1 (es) Procedimiento para la obtencion de amidas de acidos benzoheterociclilalcanoicos.
ES8102120A1 (es) Procedimiento para la obtencion de derivados de pirazol
ES8401961A1 (es) Procedimiento para la preparacion de nuevas n-(4-indolil-piperidino-alcohil-bencimidazolonas sustituidas.
HUP0001741A2 (hu) Antibakteriális hatású aza-biciklo-karbamoil-oxi-mutilin-származékok, eljárás ezek előállítására, ezeket tartalmazó készítmények és alkalmazásuk
IE790630L (en) 2, 6-dialkoxybenzamido-pyrrolidines.
ES8101590A1 (es) Un procedimiento para la preparacion de pirimido-2-benzace- pinas
ES8501748A1 (es) Un procedimiento para preparar derivados de benzamida
DE3270717D1 (en) N-(2,2,2-trifluoroethyl)-n-alkyl-azolyloxyacetic-acid amides, their preparation and use as herbicides and intermediates for their preparation
ES8103069A1 (es) Procedimiento para la preparacion de derivados de tiazolina
ES480112A1 (es) Procedimiento para la preparacion de nuevos derivados de 2- iminoimidazolidina.
ES8502118A1 (es) Procedimiento de preparar derivados de penicilina.
ES8703480A1 (es) Un procedimiento para producir un derivado de ester de cefe-losporina
ES8506005A1 (es) Procedimiento para la preparacion de derivados de quinazolina
GB1529403A (en) Isoxazole derivative
ATE37368T1 (de) Benzothiazolon-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ES8800156A1 (es) Procedimiento para preparar nuevos derivados 3-piridilmetilnaftilicos
PT73764B (en) Process for preparing novel acyl derivatives
GB1469410A (en) Benzodioxole derivatives
IL97780A0 (en) Substituted 3-thia-and 3-oxa-alkylflavones,a process for their preparation,the use thereof,medicaments based on these compounds and intermediates
ES8704163A1 (es) Un procedimiento para preparar derivados de cefem.
ES466677A1 (es) Un procedimiento de preparacion de derivados de cisteinol.
JPS5615291A (en) Oxacephamycin derivative, its preparation, and antibacterial agent consisting mainly of it
ES8506313A1 (es) Un procedimiento para la preparacion de nuevos derivados de 7-oxo-1-azabiciclo(3.2.0)hepteno.
JPS55345A (en) 2-iminobenzthiazoline derivative